Skip to content
Home/Companies/Biotech/Protagen

Protagen

Biotech·Germany·Exited 2019·Held 9yr
Entry
2010
Hold
9yr
Exit
2019

Who owns Protagen?

Protagen was owned by NRW.BANK through NRW.Venture (2006 vintage) from 2010 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

NRW.BANK
Investor
NRW.BANK
NRW.Venture · 2006 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from NRW.Venture

Other portfolio companies in the same fund.

JUPUS
Jupus
Active
LegalTechGermany· 2026
clockin
clockin
Active
SaaSGermany· 2025
Disco Pharmaceuticals
Active
BiotechGermany· 2025
eeden
Active
ClimateTechGermany· 2025
iDEL Therapeutics
Active
BiotechGermany· 2025
Lidrotec
Active
Deep TechGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Protagen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Protagen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue